Stay updated on JNJ-63623872+Oseltamivir PK/Safety in Influenza A Clinical Trial

Sign up to get notified when there's something new on the JNJ-63623872+Oseltamivir PK/Safety in Influenza A Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JNJ-63623872+Oseltamivir PK/Safety in Influenza A Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T20:49:39.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the Pharmacokinetic parameters of JNJ-63623872 in combination with oseltamivir in elderly participants compared to adults with influenza A infection.
    Difference
    0.1%
    Check dated 2024-06-06T14:22:25.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying that participants must require hospitalization for influenza treatment and must have tested positive for influenza A. Previously, no information was provided under the Participation Criteria Collaborators section.
    Difference
    22%
    Check dated 2024-05-22T20:58:18.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T21:44:37.000Z thumbnail image

Stay in the know with updates to JNJ-63623872+Oseltamivir PK/Safety in Influenza A Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JNJ-63623872+Oseltamivir PK/Safety in Influenza A Clinical Trial page.